Antibiotic Basics: Difference between revisions
(Created page with "Beta-Lactams * Penicillin * Strep Pharyngitis (including scarlet fever)Streptococcal Toxic Shock and Necrotizing Fascitis * Penicillin plus clindamycin (to decrease toxin synt...") |
No edit summary |
||
| Line 1: | Line 1: | ||
Beta-Lactams | <font size="150%">Beta-Lactams</font> | ||
* Penicillin | * '''<font size="115%">Penicillin</font>''' | ||
* Strep Pharyngitis (including scarlet fever)Streptococcal Toxic Shock and Necrotizing Fascitis | ** Strep Pharyngitis (including scarlet fever) Streptococcal Toxic Shock and Necrotizing Fascitis | ||
*** Penicillin ''plus'' clindamycin (to decrease toxin synthesis) | |||
** Meningococcus Meningitis | |||
** Syphilis (Primary, 2ndary, and latent syphilis < 1 year duration) | |||
** Actinomycosis | |||
** Anthrax | |||
** Clostridial infections | |||
** Listeria | |||
** Pasteurella | |||
* <font size="115%">'''Penicilinase-Resistant Penicillins'''</font> | |||
** Nafcillin, oxacillin, dicloxacillin | |||
*** Agents of 1st choice for treatment of S. aureus and S. epidermidis that are not methicillin-reistant | |||
* <font size="115%">'''Expanded-Spectrum Penicillins'''</font> | |||
** Ampicillin, amoxicillin (+ clavulanate) | |||
*** Upper Respiratory Infections (due to S. pyogenes, S. pneumoniae, H. influenzae) | |||
**** Sinusitis | |||
**** Otitis media | |||
**** Acute exacerbation of chronic bronchitis | |||
*** Listeria | |||
* '''<font size="115%">Antipseudomonal Penicillins</font>''' | |||
** Piperacillin | |||
*** Infection following burns | |||
*** Neutropenia | |||
* <font size="130%">'''1st Gen Cephalosporins'''</font> | |||
** Cefazolin, cephalexin | |||
*** Skin and soft tissue infections (why is agent of choice before gen sx) | |||
** Cross-reactivity of PCN allergy 7% to 18% | |||
* <font size="130%">'''2nd Gen Cephalosporins'''</font> | |||
** Cefuroxime | |||
*** Intestinal anaerobes (why is agent of chioce for colorectal sx) | |||
*** Largely displaced by 3rd gen agents | |||
* <font size="130%">'''3rd Gen Cephalosporins'''</font> | |||
** Ceftriaxone, Ceftazidime, Cefixime | |||
*** Drug of choice for serious infections due to: | |||
**** Klebsiella | |||
**** Enterobacter | |||
**** Proteus | |||
**** Haemophilus | |||
*** Gonorrhea | |||
*** Lyme disease | |||
*** Meningitis (+ vanc and ampicillin) | |||
*** Pseudomonas meningitis (+ AG) | |||
* <font size="130%">'''4th Gen Cephalosporins'''</font> | |||
** Cefepime | |||
*** Resistant, nosocomial infections | |||
* <font size="130%">'''Carbapenems'''</font> | |||
** Imipenem (+ cilastatin), meropenem | |||
*** Cephalosporin-resistant nosocomial bacteria | |||
*** Empirical treatment of serious infections in patients who recently received other b-lactams | |||
*'''Aztreonam''' | |||
** Antimicrobial activity more closely resembles AGs (only active against gram -) | |||
*** Enterobacter, pseudomonas, H. influenzae, gonococci | |||
*** Little allergic cross-reactivity with B-lactam antibiotics | |||
<font size="150%">Aminoglycosides</font> | |||
Aminoglycosides | |||
* Gentamicin, amikacin, streptomycin (either alone or with B-lactam) | * Gentamicin, amikacin, streptomycin (either alone or with B-lactam) | ||
* Serious gram-negative bacillary infections | ** Serious gram-negative bacillary infections | ||
* Ill patient with pyelonephritis | *** Ill patient with pyelonephritis | ||
* Meningitis (due to Pseudomonas, Acinetobacter) | *** Meningitis (due to Pseudomonas, Acinetobacter) | ||
* Peritoneal Dialysis–Associated Peritonitis | *** Peritoneal Dialysis–Associated Peritonitis | ||
* Bacterial endocarditis? | *** Bacterial endocarditis? | ||
* Caution: Use in patients with Myasthenia Gravis, can precipitate crisis | * Caution: Use in patients with Myasthenia Gravis, can precipitate crisis | ||
Sulfonamides | <font size="150%">Sulfonamides</font> | ||
* Trimethoprim-sulfamethoxazole | * Trimethoprim-sulfamethoxazole | ||
* 1st line for uncomplicated lower UTI (especially chronic and recurrent infections) | ** 1st line for uncomplicated lower UTI (especially chronic and recurrent infections) | ||
* PCP pneumonia | ** PCP pneumonia | ||
* Acute exacerbations of chronic bronchitis | ** Acute exacerbations of chronic bronchitis | ||
* Maxillary sinusitis | ** Maxillary sinusitis | ||
Fluoroquinolones | <font size="150%">Fluoroquinolones</font> | ||
* UTI (2nd line) | * UTI (2nd line) | ||
| Line 88: | Line 81: | ||
* PID | * PID | ||
* Traveler's diarrhea | * Traveler's diarrhea | ||
Tetracyclines | <font size="150%">Tetracyclines</font> | ||
* Mycoplasma | * Mycoplasma | ||
| Line 97: | Line 89: | ||
* Epididymitis | * Epididymitis | ||
* Anthrax | * Anthrax | ||
Macrolides | <font size="150%">Macrolides</font> | ||
* Erythromycin, Clarithromycin, Azithromycin | * Erythromycin, Clarithromycin, Azithromycin | ||
* Community-acquired PNA | ** Community-acquired PNA | ||
* Mycoplasma | ** Mycoplasma | ||
* Legionnaires' Disease | ** Legionnaires' Disease | ||
* Chlamydia (single dose) | ** Chlamydia (single dose) | ||
* H. Pylori | ** H. Pylori | ||
* Traveler's diarrhea (children and pregnant women) | ** Traveler's diarrhea (children and pregnant women) | ||
Clindamycin | <font size="150%">Clindamycin</font> | ||
* Drug of choice for lung abscess and anaerobic lung and pleural space infections | * Drug of choice for lung abscess and anaerobic lung and pleural space infections | ||
* Toxin-mediated disease, i.e. toxic shock syndrome (TSS) | * Toxin-mediated disease, i.e. toxic shock syndrome (TSS) | ||
Source: Goodman & Gilman's Pharmacology | Source: Goodman & Gilman's Pharmacology | ||
Revision as of 05:13, 10 February 2011
Beta-Lactams
- Penicillin
- Strep Pharyngitis (including scarlet fever) Streptococcal Toxic Shock and Necrotizing Fascitis
- Penicillin plus clindamycin (to decrease toxin synthesis)
- Meningococcus Meningitis
- Syphilis (Primary, 2ndary, and latent syphilis < 1 year duration)
- Actinomycosis
- Anthrax
- Clostridial infections
- Listeria
- Pasteurella
- Strep Pharyngitis (including scarlet fever) Streptococcal Toxic Shock and Necrotizing Fascitis
- Penicilinase-Resistant Penicillins
- Nafcillin, oxacillin, dicloxacillin
- Agents of 1st choice for treatment of S. aureus and S. epidermidis that are not methicillin-reistant
- Nafcillin, oxacillin, dicloxacillin
- Expanded-Spectrum Penicillins
- Ampicillin, amoxicillin (+ clavulanate)
- Upper Respiratory Infections (due to S. pyogenes, S. pneumoniae, H. influenzae)
- Sinusitis
- Otitis media
- Acute exacerbation of chronic bronchitis
- Listeria
- Upper Respiratory Infections (due to S. pyogenes, S. pneumoniae, H. influenzae)
- Ampicillin, amoxicillin (+ clavulanate)
- Antipseudomonal Penicillins
- Piperacillin
- Infection following burns
- Neutropenia
- Piperacillin
- 1st Gen Cephalosporins
- Cefazolin, cephalexin
- Skin and soft tissue infections (why is agent of choice before gen sx)
- Cross-reactivity of PCN allergy 7% to 18%
- Cefazolin, cephalexin
- 2nd Gen Cephalosporins
- Cefuroxime
- Intestinal anaerobes (why is agent of chioce for colorectal sx)
- Largely displaced by 3rd gen agents
- Cefuroxime
- 3rd Gen Cephalosporins
- Ceftriaxone, Ceftazidime, Cefixime
- Drug of choice for serious infections due to:
- Klebsiella
- Enterobacter
- Proteus
- Haemophilus
- Gonorrhea
- Lyme disease
- Meningitis (+ vanc and ampicillin)
- Pseudomonas meningitis (+ AG)
- Drug of choice for serious infections due to:
- Ceftriaxone, Ceftazidime, Cefixime
- 4th Gen Cephalosporins
- Cefepime
- Resistant, nosocomial infections
- Cefepime
- Carbapenems
- Imipenem (+ cilastatin), meropenem
- Cephalosporin-resistant nosocomial bacteria
- Empirical treatment of serious infections in patients who recently received other b-lactams
- Imipenem (+ cilastatin), meropenem
- Aztreonam
- Antimicrobial activity more closely resembles AGs (only active against gram -)
- Enterobacter, pseudomonas, H. influenzae, gonococci
- Little allergic cross-reactivity with B-lactam antibiotics
- Antimicrobial activity more closely resembles AGs (only active against gram -)
Aminoglycosides
- Gentamicin, amikacin, streptomycin (either alone or with B-lactam)
- Serious gram-negative bacillary infections
- Ill patient with pyelonephritis
- Meningitis (due to Pseudomonas, Acinetobacter)
- Peritoneal Dialysis–Associated Peritonitis
- Bacterial endocarditis?
- Serious gram-negative bacillary infections
- Caution: Use in patients with Myasthenia Gravis, can precipitate crisis
Sulfonamides
- Trimethoprim-sulfamethoxazole
- 1st line for uncomplicated lower UTI (especially chronic and recurrent infections)
- PCP pneumonia
- Acute exacerbations of chronic bronchitis
- Maxillary sinusitis
Fluoroquinolones
- UTI (2nd line)
- Prostatitis
- Chlamydia
- PID
- Traveler's diarrhea
Tetracyclines
- Mycoplasma
- Chlamydia
- PID (combined with cephalosporin)
- Epididymitis
- Anthrax
Macrolides
- Erythromycin, Clarithromycin, Azithromycin
- Community-acquired PNA
- Mycoplasma
- Legionnaires' Disease
- Chlamydia (single dose)
- H. Pylori
- Traveler's diarrhea (children and pregnant women)
Clindamycin
- Drug of choice for lung abscess and anaerobic lung and pleural space infections
- Toxin-mediated disease, i.e. toxic shock syndrome (TSS)
Source: Goodman & Gilman's Pharmacology
